Past models of the disease suggested that sunlight was a major risk factor for melanoma, but current research argues that the triggers are a

By combining two existing therapies, researchers found that they have been able to stop or reverse the progression of advanced melanoma.

The B-cell subtype is able to support immune responses against melanoma cells, thereby significantly increasing the success of immunotherapi

Research shows that between 1970 and 2009, rates of melanoma, the deadliest form of skin cancer, have increased 800% among women between the